- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03624413
InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media (InTSHA)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
South Africa has the highest burden of adolescents living with HIV in the world and adolescents are poorly prepared for transition from pediatric to adult services. For a large majority of South Africans living with HIV, ART was not available until 2004. This delay contributed to nearly 500,000 perinatal HIV infections in the late 1990s and early 2000s. With large scale-up and improved access to ART in recent years, survivors of perinatal HIV infection are now reaching adolescence and beyond. As the wave of perinatally HIV-infected adolescents matures, an estimated 320,000 adolescents will transfer from pediatric- or adolescent-based clinics to adult services in the next 10 years in South Africa. Currently, perinatally HIV-infected adolescents enter adult care at variable ages and developmental stages, without necessary preparation or support through the process. This study will develop and evaluate an innovative intervention designed to address this critical problem.
The SMART model incorporates modifiable factors such as knowledge, skills/self-efficacy, relationships and social support that can be targets of interventions to improve transition care. Medical care during adolescence is typically complicated by increased risk-taking behavior, as well as decreased caregiver involvement, which occur during a time of rapid physical, emotional, and cognitive development. When adolescents transition to adult care, they often do not receive the coordinated services that they received under pediatric care. Qualitative studies with adolescents and clinicians from sub-Saharan Africa suggest that peer support, collaboration with health providers, and communication between adult and pediatric providers might assist in transition to adult services. The SMART model emphasizes eight modifiable factors, three key stakeholders (adolescents, caregivers, and clinicians) and their interconnected relationship in influencing successful transition to adult care.The social media intervention for this study incorporates these stakeholders and addresses the modifiable factors in the SMART model to improve transition care for adolescents living with HIV.
Social media is defined as internet-based applications that allow the creation and exchange of user generated content. A recent meta-analysis found that social support was the most common reason for patients to use social media for health purposes. Social media has also been used to improve the relationship between caregivers and patients when switching caregivers, a major barrier to transition for adolescents in South Africa. Although results vary in different settings, a recent meta-analysis has shown overall improved adherence and viral suppression among adults living with HIV using social media based health services technology. Social media can address the modifiable variables in the SMART model such as knowledge, self-efficacy, goals, relationships, peer and social support, which could ultimately improve virologic suppression and retention in care during the transition to adult services.
The researchers will perform a pilot randomized controlled trial with 40 adolescents receiving the social media intervention and 40 adolescents receiving standard of care. In-depth interviews and quantitative surveys with adolescents living with HIV will be used to assess the acceptability and feasibility of the intervention. The secondary outcomes of peer support, connection to clinical staff, retention in care, and viral suppression will also be examined at baseline and 6 months after randomization.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Westville, South Africa
- University of KwaZulu-Natal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 15 to 19 years
- Perinatally HIV-infected
- Receiving ART for at least 6 months
- Fully aware of their HIV status
Exclusion Criteria:
- Inability to read and/or speak English or Zulu
- Severe mental or physical illness preventing informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Social Media Intervention
Adolescent HIV-positive participants receiving the social media intervention.
|
The social media intervention is a behavioral intervention developed by the study investigators and is delivered via mobile phones.
The intervention uses the Social-ecological Model of Adolescent and Young Adult Readiness to Transition (SMART) model, highlighting modifiable targets of intervention that can be addressed through a social media platform.
The SMART model incorporates modifiable factors such as knowledge, skills/self-efficacy, relationships and social support that can be targets of interventions to improve transition care.
The SMART model emphasizes eight modifiable factors, three key stakeholders (adolescents, caregivers, and clinicians) and their interconnected relationship in influencing successful transition to adult care.
The intervention is designed to overcome barriers and enhance facilitators to transitioning care among adolescents living with HIV who are transitioning to adult care in South Africa.
|
|
Active Comparator: Standard of Care
Adolescent HIV-positive participants receiving the standard of care.
|
Standard of care transition from pediatric to adult care for HIV.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of Intervention Measure Score
Time Frame: Month 6
|
The acceptability score is based on a validated acceptability questionnaire, the Acceptability of Intervention Measure (Proctor et al., 2011).
Acceptability of the intervention is assessed with 4 questions rated on a 5-point scale, where 1 = completely disagree and 5 = completely agree.
The total score is the average of item scores and ranges from 1 to 5 with higher scores indicating greater acceptability of the InTSHA intervention.
|
Month 6
|
|
Number of Participants Completing Intervention Sessions
Time Frame: Up to Month 6
|
Feasibility of the intervention is reported as the number of participants randomized to the InTSHA intervention who participated in 8 to 10 sessions, 5 to 7 sessions, or fewer than 5 sessions.
|
Up to Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Child and Adolescent Social Support Scale (CASSS) Score
Time Frame: Baseline, Month 6
|
Social support from peers is assessed using 10 items of the Child and Adolescent Social Support Scale (friend support subscale).
Responses are given on a 6-point scale where 1 = never and 6 = always.
Total scores range from 10 to 60, where higher scores represent greater social support from peers.
The change from baseline is calculated as the Month 6 score minus the Baseline score.
A positive value means that the scores at Month 6 increased from what they were at Baseline.
|
Baseline, Month 6
|
|
Change in Connection to Clinic Score
Time Frame: Baseline, Month 6
|
A modified version of the Working Alliance Inventory is used to measure how connected participants feel to the clinical staff and medical team.
Ten items are responded to on a 4-point scale where 0 = strongly disagree and 3 = strongly agree.
Total scores range from 0 to 30 where higher scores indicate increased feelings of connection with clinical staff.
The change from baseline is calculated as the Month 6 score minus the baseline score.
A positive value means that the scores at Month 6 increased from what they were at baseline.
|
Baseline, Month 6
|
|
Number of Participants Retained in Care
Time Frame: Up to Month 6
|
Retention in care is assessed as a composite outcome of missing any pharmacy refills of antiretroviral medication and/or missing any clinic visits in the last 6 months.
Participants are considered as retained in care if they did not miss any pharmacy refills or clinic visits.
|
Up to Month 6
|
|
HIV Viral Suppression
Time Frame: Month 6
|
HIV-1 viral load is measured in copies per milliliter (mL) and viral suppression is considered <200 copies/mL.
|
Month 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Rosenberg's Self-Esteem Scale Score
Time Frame: Baseline, Month 6
|
The Rosenberg's Self-Esteem Scale is a 10-item instrument assessing self-esteem.
Responses are given on a 4-point scale where 0 = strongly disagree and 3 = strongly agree.
Total scores range 0 to 30 and higher scores indicate greater self-esteem.
The change in score is the Month 6 score subtracted by the Baseline score.
A positive values indicates that the self-esteem score increased by the end of the study.
|
Baseline, Month 6
|
|
Change in HIV Adolescent Readiness for Transition Scale (HARTS) Score
Time Frame: Baseline, Month 6
|
The HIV Adolescent Readiness for Transition Scale (HARTS) includes 16 items that are responded to on a 5-point scale where 0 = no, 1 = no, but I am learning, 2 = yes, a little bit, 3 = yes, almost always, and 4 = yes, always.
Total scores range from 0 to 64 and higher scores indicate greater readiness to transition to adult care.
The change from baseline is calculated as the Month 6 score minus the Baseline score.
A positive value means that the scores at Month 6 increased from what they were at Baseline.
|
Baseline, Month 6
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Brian C Zanoni, MD, Emory University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00116921
- K23MH114771 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.